Home 
Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.8, p.573–578, 2022
Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.8, p.573–578, 2022
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.123, No.8, p.573–578, 2022 |
||
| Title: Hyperleptinemia as a risk factor for post-transplant diabetes mellitus development after kidney transplantation | ||
| Author: Karol GRANAK, VNUCAK Matej, Monika BELIANCINOVA, Margareta PYTLIAKOVA, Ivana DEDINSKA | ||
| Abstract: INTRODUCTION: Adipose tissue is involved in the synthesis of hormones that have an impact on food intake regulation, control of insulin sensitivity or regulation of inflammatory processes. The aim of this study was to determine the importance of adipocytokines and interleukins levels for the development of post-transplant diabetes mellitus (PTDM) after kidney transplantation (KT). MATERIAL AND METHODS: In the prospective analysis, the studied sample (n = 104) was divided into the control group, prediabetes group and PTDM group. Prior to transplantation, and subsequently, at 3, 6 and 12 months after KT, we recorded the basic characteristics of the donor and recipient, including parameters reflecting graft function, metabolic and anthropometric parameters. At the same time, we monitored the levels of adiponectin, leptin and interleukins during the monitored period. RESULTS: Using multivariate logistic regression, we identified hyperleptinemia 12 months after KT as an independent risk factor for PTDM development 1 year after KT [OR 1.0320; 95% Cl 0.9785–1.0884 (p=0.0038)]. At the same time, we confirmed that age at the time of KT is also an independent risk factor for PTDM [OR 1.0903; 95% Cl 1.0149–1.1714 (p=0.0180)]. CONCLUSION: We confirmed that elevated leptin level 12 months after KT is associated with the development of PTDM (Tab. 3, Fig. 4, Ref. 22). Text in PDF www.elis.sk |
||
| Keywords: adipocytokines, interleukins, post-transplant diabetes mellitus, kidney transplantation, leptin | ||
| Published online: 19-Jul-2022 | ||
| Year: 2022, Volume: 123, Issue: 8 | Page From: 573, Page To: 578 | |
| doi:10.4149/BLL_2022_092 |
||
|
|
 download file |
|